The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses

B. Csoma (Budapest, Hungary), A. Bikov (Budapest, Hungary), G. Szucs (Budapest, Hungary), V. Müller (Budapest, Hungary), Z. Lázár (Budapest, Hungary)

Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Session: Phenotypes of obstructive diseases
Session type: E-poster session
Number: 1245
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Csoma (Budapest, Hungary), A. Bikov (Budapest, Hungary), G. Szucs (Budapest, Hungary), V. Müller (Budapest, Hungary), Z. Lázár (Budapest, Hungary). The rate of re-exacerbation in patients hospitalized with eosinophil and non-eosinophilic COPD relapses. 1245

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Blood eosinophils and exacerbation rate in COPD patients over three years
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018



β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD
Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD
Year: 2011

The course of disease of patients who died from asthma and COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 217s
Year: 2003

The association between airway and systemic eosinophilia and symptoms and exacerbations differ between asthma and COPD patients
Source: Virtual Congress 2020 – Monitoring of inflammation in remodelling
Year: 2020


Follow-up of sputum eosinophils and cytokines during and out of exacerbations in severe refractory asthmatics
Source: Eur Respir J 2004; 24: Suppl. 48, 594s
Year: 2004

The prevelance of chronic nasal symptoms in COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 264s
Year: 2002

Rehospitalizations for an acute exacerbation among patients with COPD
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015

Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD
Source: Eur Respir J 2013; 41: 993-995
Year: 2013


Underdiagnosis of COPD in hospitalized patients
Source: Eur Respir J 2002; 20: Suppl. 38, 122s
Year: 2002

Catabolic/anabolic balance in patients with COPD exacerbation
Source: Eur Respir J 2004; 24: Suppl. 48, 305s
Year: 2004

Care-continuity for COPD patients
Source: Annual Congress 2012 - Nursing led education and follow-up strategies: impact on readmission, self care and patient experiences
Year: 2012


COPD patients
Source: Eur Respir Monogr 2021; 90: 154-164
Year: 2021


The impact of bronchiectasis on outcomes in a large cohort of patients hospitalised with exacerbations of COPD
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013

COPD patients with asthma, characteristics and risk of exacerbations
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Polypharmacy in patients hospitalised for acute exacerbation of COPD
Source: Eur Respir J 2014; 44: 791-794
Year: 2014


Anemia in COPD patients with an exacerbation
Source: Annual Congress 2011 - COPD exacerbation
Year: 2011


The comparison of eosinophilic and non-eosinophilic  stable COPD patients
Source: International Congress 2017 – Markers of COPD progression
Year: 2017


The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021



Exacerbations of severe asthma in patients treated with mepolizumab
Source: Eur Respir J, 52 (6) 1801127; 10.1183/13993003.01127-2018
Year: 2018